Join 24 National Hemp/CBD Experts
Lorem Moving To Schedule 3 == https://lnkd.in/gkN78cWM
Aliquam erat
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nulla euismod condimentum felis vitae efficitur. Sed vel dictum quam, at blandit leo.
Nostrud exerci
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nulla euismod condimentum felis vitae efficitur. Sed vel dictum quam, at blandit leo.
Nostrud exerci
Lorem ipsum dulla Key Bridge and Simplified Summary of The NEWE Project:
- Calculate Measurability Tools -- Onset// Mg and strain
- Research Grants via VA and HHS
- Super bullet proof web site & databank#2
- Future Denver Center for Treatment Modeling
- Client Intake Inventory & Health/Mental Review
- Touch, Ethics and Conditional Consent –Words and the Law
Top CBD Brands for 2026
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nulla euismod condimentum felis vitae efficitur. Sed vel dictum quam, at blandit leo.
From the Medicare Senior Members Pilot Program .... the medical MJ move to schedule 3, the SB-4315 State Opt-Out plan
to the impact of the Nov. 12th FedHempBan . Join our timely 2-day conference with global experts including:
- Jason Adelstone, Esq., Harris Slikowski
- Lloyd Covens, Conference Host, West420 News
Robert Hoban, CTrust/Arrows Law
Joe Hodas, frmr WANA Brands - frmr Dixie Elixers
Bill Kirk, Roth Capital RWH
Brian Koontz, Colorado Dept of Agriculture-
Sasha Korn-Kalcheff, Realm of Caring - Rod Kight, Kight Law**
- Dr Cassidy LoParco, George Washington University
Martin E. Lee, Project CBD -
Art Massolo, Live Happy/ frmr Cycling Frog - Darwin Millard, ASTM Group -
Bernard Perry, Restorative Botanicals -- - Kehrt Reyher, HEMP Today
- David Segui, Segui Law
- Steph Sherer, Founder, Americans for Safe Access
Jared Stanley, co-Founder, Charlottes' Web/ AJNA DeFloria - Eric Taubel, Minnesota Office of Cannabis Management
- TBA, Lobbyist for Failed SB 1064, Vicente LLC
Jordan Wellington, Founder, Strategies 64 - -Perspectives from key Washington staff of Sen Jeff Merkley(D-OR) -- or Rep. Morgan Griffiths(R-VA) -- Sen John Hickenlooper (D-CO)
2026 MedMJ Milestones to Sked3
Compiled by Americans for Safe Access--
2. DEA: The new Notice of Hearing on Proposed Rulemaking (NHPRM): Docket No. DEA-1362; Attorney General Order No. 6753-2026: "Every 'interested person' as defined in 21 CFR 1300.01(b) as 'any person adversely affected or aggrieved by any rule or proposed rule issuable' who wishes to participate in the hearing shall file a written notice of intention to participate. Electronic filing may be made as a PDF attachment via email to the Drug Enforcement Administration, Attn: Administrator at nprm@dea.gov, on or before 11:59 p.m. Eastern Time on May 24, 2026.
May 24, 2026: Deadline for "interested party" submissions to NHPRM
June 26, 2026: Deadline for medical cannabis businesses to register with the DEA
June 29, 2026: New Administrative hearing set to begin for broader marijuana rescheduling.
July 15, 2026: The new administrative hearing will conclude, according to the DOJ Press Release
November 2026: Changes to federal hemp law are expected to take effect, which may affect some hemp-derived cannabinoid products. This is separate from the DOJ/DEA medical cannabis order but may affect patients using full-spectrum CBD or other hemp-derived products. 7 U.S.C. § 1639o — Hemp Definition
December 26, 2026: 6-month target for DEA to approve medical cannabis registrations
